PD-L1 as the Prognostic Immune Biomarker for Predicting the Relapse of Locally Advanced Cervical Adenocarcinoma and Adenosquamous Carcinoma Treated With Definitive Chemoradiation Therapy
International Journal of Radiation Oncology Biology Physics - Netherlands
doi 10.1016/j.ijrobp.2017.06.1318
Full Text
Open PDFAbstract
Available in full text
Date
October 1, 2017
Authors
Publisher
Elsevier BV